Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

HPV not likely to be transmitted through the hand, shows study

Commonly known as HPV, Human papillomavirus is a virus that infects the skin and genital area, in many cases leading to a variety of genital, anal, and oropharyngeal cancers in men and women. Strong evidence exists showing that penetrative genital sex and oral sex can transmit HPV.

12 Feb 2019

Immunotherapy drug can be effective in treating patients with recurrent brain tumors

A UCLA-led study suggests that for people with recurrent glioblastoma, administering an immunotherapy drug before surgery is more effective than using the drug afterward.

11 Feb 2019

Watchful waiting in prostate cancer becoming more popular

In 2010, the US National Comprehensive Cancer Network guidelines suggested that patients with stable and low-risk prostate cancers could be managed with active surveillance or watchful waiting (AS/WW). AS/WW was considered to be a safe and effective alternative to aggressive surgery to remove the prostate and radiation therapy.

11 Feb 2019

Trojan Horse approach to cancer therapy shows promise

A new form of cancer fighting drug has been developed using the principles of the “Trojan Horse”.

11 Feb 2019

New technique uses acoustic waves to measure the stiffness of living cells

MIT engineers have devised a new, noninvasive way to measure the stiffness of living cells using acoustic waves. Their technique allows them to monitor single cells over several generations and investigate how stiffness changes as cells go through the cell division cycle.

11 Feb 2019

Using Therapy Dogs to Reduce Stress and Improve Emotional Well-Being in Vulnerable Individuals

There is much research that shows that therapy dogs can help reduce stress and improve emotional well-being in vulnerable individuals. Rachel McPherson talks about this research that the work done by The Good Dog Foundation.

11 Feb 2019

Immunotherapy may be better than chemotherapy for Merkel cell carcinoma

The first study of the immunotherapy drug pembrolizumab as the initial treatment for patients with a rare but aggressive form of skin cancer known as Merkel cell carcinoma reports better responses and longer survival than expected with conventional chemotherapy.

11 Feb 2019

Stereotactic body radiotherapy effective in treating men with low- or intermediate-risk prostate cancer

A new UCLA-led study shows that men with low- or intermediate-risk prostate cancer can safely undergo higher doses of radiation over a significantly shorter period of time and still have the same, successful outcomes as from a much longer course of treatment.

11 Feb 2019

New cancer drug that acts as ‘Trojan horse’ shows promise in patients with various cancers

A brand new type of cancer drug that acts as a 'Trojan horse' to get inside tumor cells has shown promise in patients with six different cancer types.

11 Feb 2019

Study finds low relapse risk in young patients with Hodgkin lymphoma

The treatment of Hodgkin lymphoma is now so effective that young patients who do not have a relapse within two years of therapy have a life expectancy similar to that of their healthy peers.

8 Feb 2019

'Trojan horse' drug shows promise for untreatable cancers

A new cancer drug that uses a ‘Trojan horse’ approach to destroy cancer cells from within has shown promising results for patients with untreatable cancers.

8 Feb 2019

Immunotherapy drug found to be effective in patients with advanced Merkel cell carcinoma

A multi-center phase II clinical trial investigating pembrolizumab as a first-line and programmed cell death-1 therapy in patients with advanced Merkel cell carcinoma reports lasting tumor control, generally manageable side effects and improved overall survival.

8 Feb 2019

UNC-led scientists receive $5.1 million grant to combat cervical cancer in Malawi

Backed by a $5.1 million grant, University of North Carolina and University of Malawi College of Medicine physicians and scientists will launch a multi-pronged effort to combat cervical cancer in Malawi, a country in sub-Saharan Africa where cervical cancer is the leading cause of cancer death among women.

7 Feb 2019

MUSC researchers examine the way estrogen affects drug addiction

Male rats have held steady as the focus of most addiction studies in the past. But as the field begins to take female rats into account, scientists see that drugs like methamphetamine affect the sexes differently, suggesting the basis for a change in addiction treatment.

7 Feb 2019

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

The U.S. Food and Drug Administration today approved Cablivi (caplacizumab-yhdp) injection, the first therapy specifically indicated, in combination with plasma exchange and immunosuppressive therapy, for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura (aTTP), a rare and life-threatening disorder that causes blood clotting.

7 Feb 2019

Physicians more likely to prescribe drugs of manufacturers who paid them money

In a study published in The Oncologist, physicians treating certain cancers who consistently received payments from a cancer drug's manufacturer were more likely to prescribe that drug over alternative treatments.

6 Feb 2019

Rare stem cell may be the root of all metastatic cancers

Researchers have discovered a rogue stem cell that could be the cause of all metastatic cancers. The breakthrough could affect all future research projects.

6 Feb 2019

Exploring racial disparities in social support needs among breast cancer patients

In a Psycho-Oncology study of 28 women who were being treated for breast cancer and were participating in focus groups, White participants noted that having other breast cancer survivors in their support network was essential for meeting their social support needs.

6 Feb 2019

Non-cancerous ovarian cysts need not be removed surgically, suggests study

Women may not need to undergo surgery for non-cancerous ovarian cysts, avoiding potential surgical complications.

5 Feb 2019

Drug treating breast cancer may be effective in treating lung and ovarian cancer

Two new papers, published simultaneously in Nature Communications and led by researchers at McGill University, offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer, one rare and one common form.

5 Feb 2019

Oncology News and Research

Further Reading

HPV not likely to be transmitted through the hand, shows study

Immunotherapy drug can be effective in treating patients with recurrent brain tumors

Watchful waiting in prostate cancer becoming more popular

Trojan Horse approach to cancer therapy shows promise

New technique uses acoustic waves to measure the stiffness of living cells

Using Therapy Dogs to Reduce Stress and Improve Emotional Well-Being in Vulnerable Individuals

Immunotherapy may be better than chemotherapy for Merkel cell carcinoma

Stereotactic body radiotherapy effective in treating men with low- or intermediate-risk prostate cancer

New cancer drug that acts as ‘Trojan horse’ shows promise in patients with various cancers

Study finds low relapse risk in young patients with Hodgkin lymphoma

'Trojan horse' drug shows promise for untreatable cancers

Immunotherapy drug found to be effective in patients with advanced Merkel cell carcinoma

UNC-led scientists receive $5.1 million grant to combat cervical cancer in Malawi

MUSC researchers examine the way estrogen affects drug addiction

First therapy indicated for treating adults with rare blood clotting disorder receives FDA approval

Physicians more likely to prescribe drugs of manufacturers who paid them money

Rare stem cell may be the root of all metastatic cancers

Exploring racial disparities in social support needs among breast cancer patients

Non-cancerous ovarian cysts need not be removed surgically, suggests study

Drug treating breast cancer may be effective in treating lung and ovarian cancer

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News